Hematology NewsCMML: GM-CSF inhibitor lenzilumab shows early promiseJune 20, 2023CMLAMLMyelodysplastic SyndromeMixed Topics
Oncology PracticeWidespread carboplatin, cisplatin shortages: NCCN surveyJune 9, 2023Patient & Survivor CarePractice ManagementLung CancerBreast CancerGenitourinary CancerNonmelanoma Skin CancerMetastatic Breast Cancer
Hematology NewsASCO honors Hagop Kantarjian, MD, for leukemia researchMay 16, 2023CMLALLAMLBusiness of MedicineMixed TopicsMyelodysplastic Syndrome
Oncology PracticeNumber of cancer survivors with functional limitations doubled in 20 yearsMay 11, 2023Patient & Survivor CareLung CancerDiversity in MedicineBreast CancerMixed TopicsLymphoma & Plasma Cell DisordersLeukemia, Myelodysplasia, Transplantation
Hematology NewsMomelotinib hits the mark for deadly bone marrow cancerJune 13, 2022CMLAnemiaMixed Topics
Hematology NewsThird-generation Black woman physician makes cancer research historyMay 24, 2022Mixed TopicsALLB Cell LymphomaHodgkin LymphomaMantle Cell LymphomaDiversity in MedicineAML
Hematology NewsU.S. cancer deaths continue to fall, especially lung cancerJanuary 13, 2022Breast CancerMelanomaCMLLung Cancer
Better clinical outcomes with adjuvant IFN therapy vs. adjuvant vaccine in TKI-treated patients with CML-CPNovember 30, 2021CML
Statins enhance molecular response rates in imatinib-treated patients with CML-CPNovember 30, 2021CML
